(BPT) - Ataxia, a rare and progressive neurological disease, affects nearly 150,000 people in the U.S. A new clinical study will measure if troriluzole, an investigational drug, will improve ataxia symptoms in people with spinocerebellar ataxia (SCA). Learn more at www.scatrial.org.

Recommended for you